Ampio Pharmaceuticals CEO Michael Macaluso's 2017 pay jumps 88% to $573.0K

Ampio Pharmaceuticals reports 2017 executive compensation

Published: December 31, 1969

Ampio Pharmaceuticals reported fiscal year 2017 executive compensation information on December 31, 1969.

In 2017, five executives at Ampio Pharmaceuticals received on average a compensation package of $357.4K, a 34% increase compared to previous year.

Average pay of disclosed executives at Ampio Pharmaceuticals

Michael Macaluso, Chief Executive Officer, received $573K in total, which increased by 88% compared to 2016. 52.35% of Macaluso's compensation, or $300K, was in salary. Macaluso also received $5K in bonus and $268K in option awards.

Thomas E. Chilcott, Chief Financial Officer, received a compensation package of $391.8K. 43.48% of the compensation package, or $170.4K, was in option awards.

David Bar-Or, Chief Scientific Officer, earned $351.7K in 2017, a 15% increase compared to previous year.

Holli Cherevka, Chief Operating Officer, received $324.1K in 2017.

Gregory A. Gould, Chief Financial Officer, earned $146.4K in 2017, a 62% decrease compared to previous year.